Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine vs Placebo for Stress Ulcer Prophylaxis in Infants with CHD
NCT03667703Phase 4Completed
- Sponsor
- Boston Children's Hospital
- Start
- Mar 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of famotidine in stress ulcer, upper gastrointestinal bleeding (UGIB), sponsored by Boston Children's Hospital. Started Mar 2019; status: completed.
02
Drugs
famotidine
03
Conditions
stress ulcerupper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT03667703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03667703.